Literature DB >> 1600693

The accuracy and clinical interpretation of serum ferritin assays.

D W Dawson1, D I Fish, P Shackleton.   

Abstract

The accuracy of methods used to assay serum ferritin was determined in two ways. In one a serum, to which the UK ferritin standard had been added, was issued to the participants in an inter-regional quality assurance scheme. The overall recovery was close to that expected. For the second assessment a series of sera from individuals of known iron status were issued. Differences between assay results related to the method of assay though the immunoradiometric and ELISA methods gave results which were close to each other. The variation in clinical interpretation applied to assay results when ferritin concentrations around the upper and lower limits of normal were assayed was more than could be accounted for by method imprecision and indicates that inappropriate reference ranges are in common use. 'Indeterminate', a proper clinical interpretation when the imprecision of a technique should prevent a definite response, was inadequately used.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1600693

Source DB:  PubMed          Journal:  Clin Lab Haematol        ISSN: 0141-9854


  3 in total

1.  The effect of iron in formula milk after 6 months of age.

Authors:  D Stevens; A Nelson
Journal:  Arch Dis Child       Date:  1995-09       Impact factor: 3.791

2.  Therapeutic value of combined therapy with deferasirox and silymarin on iron overload in children with Beta thalassemia.

Authors:  Adel A Hagag; Mohamed S Elfrargy; Rana A Gazar; Aml Ezzat Abd El-Lateef
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-11-04       Impact factor: 2.576

Review 3.  Performance and comparability of laboratory methods for measuring ferritin concentrations in human serum or plasma: A systematic review and meta-analysis.

Authors:  Maria N Garcia-Casal; Juan P Peña-Rosas; Eloisa Urrechaga; Jesus F Escanero; Junsheng Huo; Ricardo X Martinez; Lucero Lopez-Perez
Journal:  PLoS One       Date:  2018-05-03       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.